Fludarabine trials for Sickle cell disease

All Fludarabine trials · All Sickle cell disease trials

Phase breakdown

Recruiting trials studying Fludarabine for Sickle cell disease

• A Study of Immune Suppression Treatment for People With Sickle Cell Disease or β-Thalassemia Who Are Going to Receive an Allogeneic Hematopoietic Cell Transplantation (HCT)
  NCT05736419 · Phase: Phase 2 · Ages: 2 Years to 50 Years · Sex: All (male and female) · 6 locations
• Allo HSCT for High Risk Hemoglobinopathies
  NCT06872333 · Phase: Phase 2 · Ages: Up to 55 Years · Sex: All (male and female) · 1 location
• Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT
  NCT01962415 · Phase: Phase 2 · Ages: 2 Months to 55 Years · Sex: All (male and female) · 2 locations
• Study of HLA-Haploidentical Stem Cell Transplantation to Treat Clinically Aggressive Sickle Cell Disease
  NCT03121001 · Phase: Phase 2 · Ages: 16 Years to 60 Years · Sex: All (male and female) · 1 location
• T-Cell Depleted Alternative Donor Bone Marrow Transplant for Sickle Cell Disease (SCD) and Other Anemias
  NCT03653338 · Phase: Phase 1, Phase 2 · Ages: 5 Years to 40 Years · Sex: All (male and female) · 1 location

Common questions

How many trials study Fludarabine for Sickle cell disease?

5 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.